Cargando…
The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
Ameet Sarpatwari and Aaron Kesselheim explore whether stripping branded drugs of trademark protection would improve the efficiency and fairness of health care.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747525/ https://www.ncbi.nlm.nih.gov/pubmed/26859662 http://dx.doi.org/10.1371/journal.pmed.1001955 |